يعرض 5,721 - 5,740 نتائج من 19,776 نتيجة بحث عن '(( significantly ((a decrease) OR (mean decrease)) ) OR ( significant increase decrease ))', وقت الاستعلام: 0.36s تنقيح النتائج
  1. 5721

    Numerical Rating Scale (NRS). حسب Na Wang (193263)

    منشور في 2024
    "…</p><p>Results</p><p>We found that numerical rating scale(NRS) score and incidence of breast fistula in group A were significantly lower than other, the continuous decrease of postoperative drainage in group A was higher than other, there were significant differences among groups (p<0.001). …"
  2. 5722

    Mammary fistula (n(%)). حسب Na Wang (193263)

    منشور في 2024
    "…</p><p>Results</p><p>We found that numerical rating scale(NRS) score and incidence of breast fistula in group A were significantly lower than other, the continuous decrease of postoperative drainage in group A was higher than other, there were significant differences among groups (p<0.001). …"
  3. 5723

    Forest maps affecting lactation outcomes. حسب Na Wang (193263)

    منشور في 2024
    "…</p><p>Results</p><p>We found that numerical rating scale(NRS) score and incidence of breast fistula in group A were significantly lower than other, the continuous decrease of postoperative drainage in group A was higher than other, there were significant differences among groups (p<0.001). …"
  4. 5724

    Postoperative drainage(ml) (M(IQR)). حسب Na Wang (193263)

    منشور في 2024
    "…</p><p>Results</p><p>We found that numerical rating scale(NRS) score and incidence of breast fistula in group A were significantly lower than other, the continuous decrease of postoperative drainage in group A was higher than other, there were significant differences among groups (p<0.001). …"
  5. 5725
  6. 5726
  7. 5727
  8. 5728
  9. 5729
  10. 5730
  11. 5731
  12. 5732

    Discovering a novel dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) inhibitor and its impact on tau phosphorylation and amyloid-β formation حسب Huang-Ju Tu (630766)

    منشور في 2024
    "…Although the development of DYRK1A inhibitors has significantly advanced in recent years, the selectivity of these drugs remains a critical challenge, potentially impeding further progress. …"
  13. 5733
  14. 5734
  15. 5735
  16. 5736
  17. 5737
  18. 5738
  19. 5739
  20. 5740